Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue
- PMID: 20189442
- DOI: 10.1016/j.oraloncology.2010.01.019
Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue
Abstract
The relatively modest survival of patients surgically treated for advanced HNSCC can partly be explained by the development of local relapse. It is important that surgeons are able to predict which patients are at high risk to develop local relapse, since clinical management can be tailored. Local relapse after resection of a primary HNSCC is easily explained, when tumour is detected in the surgical margins and thus residual tumour is likely to remain in the patient, but the pathobiology is more complex in cases where the margins are histologically tumour-free. Molecular studies indicate that there are two different mechanisms responsible in these cases. First, small clusters of residual tumour cells that are undetectable on routine histopathological examination (known as minimal residual cancer: MRC) proliferate and this forms the basis of recurring cancer. A second cause of relapse is a remaining field of preneoplastic cells that is struck by additional genetic hits leading to invasive cancer. It is likely that within this field, that can be over 7cm in diameter, the primary carcinoma has also emerged. Despite careful histopathological examination of the surgical margins of the primary carcinoma, it is at present not reliably possible to predict which patient will develop local relapse. Herein we focus on new developments regarding the analysis of margins, causes of local relapse, and how novel molecular techniques can be of help in a more accurate risk assessment. Critical analysis of the studies that have been published thus far shows that there is a list of promising markers, based on protein expression (immuno-histochemistry) and nucleic acid analysis. Further studies should be focused on validation and assessment of the clinical utility of these markers. Margin analysis should reveal whether one is dealing with residual cancer cells that might be treated by post-operative radiotherapy or with preneoplastic fields that remained behind. For this latter entity, there is no intervention available at present, except for a more intensive surveillance.
Similar articles
-
Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.J Pathol. 2002 Dec;198(4):476-86. doi: 10.1002/path.1242. J Pathol. 2002. PMID: 12434417
-
Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.Clin Cancer Res. 2004 Jun 1;10(11):3614-20. doi: 10.1158/1078-0432.CCR-03-0631. Clin Cancer Res. 2004. PMID: 15173067
-
Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.Clin Cancer Res. 2004 Jun 1;10(11):3607-13. doi: 10.1158/1078-0432.CCR-03-0632. Clin Cancer Res. 2004. PMID: 15173066
-
Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications.Curr Opin Otolaryngol Head Neck Surg. 2007 Apr;15(2):74-81. doi: 10.1097/MOO.0b013e328058670f. Curr Opin Otolaryngol Head Neck Surg. 2007. PMID: 17413406 Review.
-
Second field tumors: a new opportunity for cancer prevention?Oncologist. 2005 Aug;10(7):493-500. doi: 10.1634/theoncologist.10-7-493. Oncologist. 2005. PMID: 16079316 Review.
Cited by
-
Expanding the foundation for personalized medicine: implications and challenges for dentistry.J Dent Res. 2013 Jul;92(7 Suppl):3S-10S. doi: 10.1177/0022034513487209. Epub 2013 May 20. J Dent Res. 2013. PMID: 23690361 Free PMC article. Review.
-
Prognostic factors in oral and oropharyngeal cancer based on ultrastructural analysis and DNA methylation of the tumor and surgical margin.Tumour Biol. 2014 Aug;35(8):7441-9. doi: 10.1007/s13277-014-1958-1. Epub 2014 May 1. Tumour Biol. 2014. PMID: 24782031 Free PMC article.
-
Surgical margins and its evaluation in oral cancer: a review.J Clin Diagn Res. 2014 Sep;8(9):ZE01-5. doi: 10.7860/JCDR/2014/9755.4836. Epub 2014 Sep 20. J Clin Diagn Res. 2014. PMID: 25386547 Free PMC article. Review.
-
Next-generation sequencing in clinical oncology: next steps towards clinical validation.Cancers (Basel). 2014 Nov 18;6(4):2296-312. doi: 10.3390/cancers6042296. Cancers (Basel). 2014. PMID: 25412366 Free PMC article. Review.
-
13-gene DNA Methylation Analysis from Oral Brushing: A Promising Non Invasive Tool in the Follow-up of Oral Cancer Patients.J Clin Med. 2019 Dec 2;8(12):2107. doi: 10.3390/jcm8122107. J Clin Med. 2019. PMID: 31810211 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical